These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32515557)

  • 21. Myocardial Edema and Prognosis in Amyloidosis.
    Kotecha T; Martinez-Naharro A; Treibel TA; Francis R; Nordin S; Abdel-Gadir A; Knight DS; Zumbo G; Rosmini S; Maestrini V; Bulluck H; Rakhit RD; Wechalekar AD; Gilbertson J; Sheppard MN; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2018 Jun; 71(25):2919-2931. PubMed ID: 29929616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of cardiac amyloid with [
    Möckelind S; Axelsson J; Pilebro B; Lindqvist P; Suhr OB; Sundström T
    Amyloid; 2020 Sep; 27(3):191-199. PubMed ID: 32400202
    [No Abstract]   [Full Text] [Related]  

  • 27. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
    Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
    Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of Myocardial
    Papathanasiou M; Kessler L; Bengel FM; Jakstaite AM; Kersting D; Varasteh Z; Luedike P; Carpinteiro A; Herrmann K; Rassaf T; Rischpler C
    J Nucl Med; 2023 Jul; 64(7):1083-1086. PubMed ID: 37290801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy.
    Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S
    AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
    Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
    Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
    Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current role of imaging techniques in cardiac amyloidosis.
    Pudis M; Bastarrika Alemañ G
    Med Clin (Barc); 2023 Feb; 160(3):121-128. PubMed ID: 36543710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
    Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
    Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
    Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not All Heart Uptakes on 99mTc-DPD Scintigraphy Are Amyloidosis: Chloroquine-Induced Cardiomyopathy.
    Wakfie-Corieh CG; Ramos López N; Saiz-Pardo Sanz M; Pérez Castejón MJ; Vilacosta I
    Clin Nucl Med; 2021 Apr; 46(4):e188-e189. PubMed ID: 33208614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of
    Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
    Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.
    Bianco M; Parente A; Biolè C; Righetti C; Spirito A; Luciano A; Destefanis P; Nangeroni G; Angusti T; Anselmino M; Montagna L
    J Nucl Cardiol; 2021 Jun; 28(3):825-830. PubMed ID: 33728572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spleen visualization in both TTR and AL amyloidosis during
    Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
    Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.